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Production of a Fluorescence Resonance Energy Transfer (FRET) 
Biosensor Membrane for MicroRNA Detection 
Yike Fua, Tong Chena, Tongxu Gua, Yuxi Xiea, Yu Luoa, Gang Wanga, Congkun Xiea, Jie Huangb, Xiang 
Lia*, Serena Bestc, Gaorong Hana* 
MicroRNAs (miRNAs) play a key role in regulating gene expression but can be associated with abnormalities linked to 
carcinogenesis and tumor progression. Hence there is increasing interest in developing methods to detect these non-
coding RNA molecules in the human circulation system. Here, a novel FRET miRNA-195 targeting biosensor, based on silica 
nanofibers incorporated with rare earth-doped calcium fluoride particles (CaF2:Yb,Ho@SiO2) and gold nanoparticles 
(AuNPs), is reported. The formation of a sandwich structure, as a result of co-hybridization of the target miRNA which is 
captured by oligonucleotides conjugated at the surface of CaF2:Yb,Ho@SiO2 fibers and AuNPs, brings the nanofibers and 
AuNPs into close proximity and triggers the FRET effect. The intensity ratio of green to red emission, I541/I650, was found to 
decrease linearly with increasing concentration of the target miRNA and this can be utilized as a standard curve for 
quantitative determination of miRNA concentration. This assay offers a simple and convenient method for miRNA 
quantification, with the potential for rapid and early clinical diagnosis of diseases such as breast cancer. 
1 Introduction 
There is increasing concern about the very high numbers of breast 
cancer-related deaths worldwide. In 2012, there were more than 
1.7 million diagnosed cases, 521,900 deaths and overall, the disease 
represents 15% of cancer deaths in the female population.1 Hence, 
there is an urgent need for the development of early detection 
methodologies to expand and inform treatment options and offer 
the potential for improved clinical outcome. 
MicroRNAs (miRNAs), a class of small noncoding RNA molecules 
(~22 nucleotides in length), are thought to be involved in the 
regulation of ~30 % of human genes and to play a role in a range of 
biological processes including, the cell cycle, differentiation and 
metabolism. 2-5 They are also believed to be associated with human 
diseases such as diabetes, neurodegenerative or immuno- disorders 
and cancer.5 The de-regulation or dysfunction of miRNAs plays an 
important role in carcinogenesis and disease progression. Since the 
existence of miRNAs in the circulatory system was confirmed, the 
expression profile of serum miRNAs has emerged as a promising 
and convenient diagnostic bio-marker for non-invasive, early-stage 
disease detection.6, 7 MiRNA-195 (miR-195) has been shown to play 
an important role in breast tumorigenesis.8 For example, blood-
based miRNA profiling studies demonstrated that systemic miR-195 
levels were raised in breast cancer patients, but decreased after 
surgery.9, 10 Thus, rapid and efficient detection of miR-195 is 
essential for early diagnosis of breast cancer. 
However, the detection of miRNAs in clinical samples is 
challenging due to their short sequences, single base differences 
and extremely low concentration.11, 12 Various sensing mechanisms 
have been developed for miRNA measurement, including 
electrochemical and electromechanical biosensing and surface 
plasmon resonance.13-15  
Fluorescence resonance energy transfer (FRET), in which the 
electronic excitation energy of an energy donor chromophore is 
transferred to an energy acceptor in the presence of a target, has 
been used previously in miRNA detection.16-18 Traditional 
fluorophores used in FRET-based detection include Cy5, FAM and 
Texas red. However, these are  limited by intrinsic drawbacks 
including broad emission bands and photobleaching effects.19  
To address these issues, alternative methods have been 
explored, such as those based on upconversion photoluminescent 
(UCPL) nanomaterials. These materials offer the advantages of high 
quantum yields, narrow emission peaks, long lifetimes, superior 
photostability, deep penetration and low toxicity.20-24 More 
importantly, upconversion is a process where low-energy light, 
(usually near-infrared (NIR) or infrared (IR)) is converted to higher-
energy light (UV or visible), through multiple photon absorptions or 
energy transfers. This property does not occur in natural biological 
materials.25, 26 Therefore, there is no background auto-fluorescence 
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from biological systems, which means that the signal-to-noise ratio 
and sensitivity of the detection is high.27 These advantages have 
made UCPL materials an ideal choice as the fluorescence donor in 
FRET-based biological detection. 
Fluoride materials (such as NaYF4) have been investigated 
extensively  as matrices for rare earth doping28-30 and, in particular, 
the unique NIR-to-visible UCPL properties and low phonon energies 
of CaF2 nanomaterials offer the potential to minimize multiphonon 
de-excitation. In addition, when these materials are doped with 
rare earth elements, the energy transfer rate can be accelerated 
due to charge compensation effects, the promotion of pair 
formation and the influence on lattice structure - all of which 
enhance the probability of UC.31, 32 However, despite these 
advantages, there appears to have been little work on the use of 
rare earth-doped CaF2 in FRET-based technology for the detection 
of biomolecules such as miRNA. To date reports have focused on 
the production of CaF2:Yb,Ho for optical applications33 and the use 
of CaF2:Ce,Tb in avidin and uPAR detection in particulate form34. 
Gold nanoparticles (AuNPs) have been used extensively to 
quench fluorescence signals. They have also been used in gene 
delivery applications35-37, and have been used to detect 
immunoglobulin G and ss-DNA38, 39, but there does not appear to 
have been work reported on the detection of miRNA-195 
sequences.  
In a FRET-based detection system, it is necessary to ensure a 
spectral overlap between the emission of the donor and the 
absorption of acceptor. The absorption of gold nanoparticles with a 
diameter of 10-20 nm is usually located in the green region.19, 40 
Therefore, strong green emission from the energy donor is essential 
for FRET effects, in order to optimise the sensitivity. 
Photoluminescent CaF2:Yb,Er embedded in SiO2 nanofibers have 
been used in drug delivery41. However, the fact that silica 
nanofibers have a high surface area and also offer a high density of 
OH groups on their surface means that they have the capacity to 
bind high numbers of DNA probes along their fiber surfaces and 
thereby offer the potential to facilitate miRNA detection. The 
processing properties of the nanofibers means that they can be 
processed to form a membrane and hence offer high levels of ease 
of handling.  
Therefore, in order to develop a practical and functional 
biosensor, in this study, Yb and Ho co-doped CaF2 (CaF2:Yb,Ho) 
nanoparticles were synthesized using a hydrothermal process and 
were incorporated into electrospun SiO2 nanofibers 
(CaF2:Yb,Ho@SiO2) (Figure 1).  
Two complementary miRNA-capturing oligonucleotides were 
selected to bind to two either end of the same miRNA target 
molecule. The CaF2:Yb,Ho@SiO2 nanofibers were modified with 
amino groups to interact with a carboxyl group-functionalized 
miRNA-capturing oligonucleotide (Probe 1). Gold nanoparticles 
were conjugated with a thiol-modified miRNA-capturing 
oligonucleotide (Probe 2). When miRNA-195 was added into the 
system, it was therefore captured by the two different 
oligonucleotides and a sandwich-like complex was formed, as 
shown in Figure 1. Via this sandwich-type hybridization, the process 
led to AuNPs and CaF2:Yb,Ho@SiO2 nanofibers being brought 
sufficiently close together to trigger the FRET effect, and the green 
emission of CaF2:Yb,Ho@SiO2 nanofibers was absorbed by the 
AuNPs. By measuring the change in the fluorescence properties 
under 980 nm irradiation, a quantitative measurement of the target 
miRNA can be obtained. 
2 Results and discussion 
2.1 CaF2:Yb,Ho nanoparticles  
Scanning electron microscopy (SEM) indicated that the 
CaF2:Yb,Ho nanoparticles synthesized hydrothermally at 180 °C 
were spheroidal in morphology with a relatively monodisperse 
particle size of approximately 320 nm (Figure 2a). Figure S1 
shows the particle diameter distribution. Transmission 
electron microscopy (TEM) revealed that the spheroidal 
nanoparticles were composed of aggregates of primary 
crystallites (Figure 2b). Lattice imaging using HRTEM shows 
clear lattice fringes indicating that the nanoparticles were 
highly crystalline (Figure 2c). Interplanar spacings of 0.276 nm 
and 0.310 nm were measured in two adjacent crystals and 
these dimensions correspond to the (200) and (111) planes of 
CaF2 respectively (JCPDS No. 35-0816). The XRD pattern for the 
CaF2:Yb,Ho nanoparticles shows that all of the diffraction 
peaks matched well with the standard pattern for cubic CaF2 
(JCPDS No. 35-0816) (Figure 3d). No obvious impurity peaks 
were observed, suggesting that the Yb3+ and Ho3+ ions were 
successfully incorporated into CaF2 lattice. After sintering at 
 
Figure 1 Schematic illustration for the synthesis of miRNA 
nanosensor based on CaF2:Yb,Ho@SiO2 nanofibers and AuNPs. 




Figure 2 (a) SEM (b) TEM and (c) HRTEM images of CaF2:Yb,Ho 
nanoparticles produced using hydrothermal synthesis at 180 °C. 
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700 °C, the nanoparticles had a similar morphology to the 
uncalcined material (Figure S2), but the sharper XRD peaks 
suggested that crystallinity had increased. Under irradiation at 
980 nm, the CaF2:Yb,Ho nanoparticles exhibited two main 
upconversion emissions (Figure 3e). The green emission at 
about 541 nm is ascribed to the 5F4,5S2→5I8 transition, and the 
relatively weak red emission at about 650 nm is assigned to a 
5F5→5I8 transition (Figure S3).42 Yb3+ ions act as sensitizers in 
the system, which absorb infrared radiation (980 nm) and non-
radiatively transfer their excitation to Ho3+ ions, thus 
populating not only the emitting levels but also the 
intermediate levels.43, 44 
2.2 Electrospinning of CaF2:Yb,Ho@SiO2 nanofibers  
The CaF2:Yb,Ho@SiO2 nanofibers were prepared by 
electrospinning. Figure 3a shows an optical image of an 
electrospun CaF2:Yb,Ho@SiO2 nanofiber membrane. Using 
SEM, the composite nanofibers were observed to have a 
smooth surface morphology and a diameter of approximately 
490 nm (Figure 3b). TEM images revealed that the CaF2:Yb,Ho 
nanoparticles were uniformly-distributed and along the length 
of the SiO2 nanofibers (Figure 3c). The presence of amorphous 
SiO2 was also confirmed from the XRD trace (Figure 3d), by the 
presence of a broad peak at ~23 °. The other sharp peaks, 
which are similar to the pattern of CaF2:Yb,Ho nanoparticles, 
can be assigned to the particle phase in the nanofibers. In 
addition, the upconversion photoluminescence spectrum of 
CaF2:Yb,Ho@SiO2 nanofibers under 980 nm irradiation was 
similar to the spectrum of the CaF2:Yb,Ho nanoparticles, 
although emission intensity was weakened by 75 % when the 
particles were incorporated into SiO2. This was due to the 
quenching effect of surface groups with high vibration 
frequency, such as -OH groups on the SiO2 nanofibers. Sol–gel 
SiO2 nanofibers have been investigated widely in 
nanomedicine due to their biocompatibility and ease of 
chemical decoration. The CaF2:Yb,Ho particle embedded SiO2 
nanofibers produced in this work, possess the advantages of 
SiO2 nanofibers while ensuring the upconversion 
photoluminescence features of CaF2:Yb,Ho nanoparticles 
allowing the detection of miRNA via a FRET effect. 
2.3 Conjugation of Probe 1 with CaF2:Yb,Ho@SiO2 
Prior to oligonucleotide conjugation, the CaF2:Yb,Ho@SiO2 
nanofibers were functionalized with amino groups using 
APTES. The CaF2:Yb,Ho@SiO2 nanofibers were characterized 
before- and after amino modification using FTIR to 
demonstrate surface functionalization (Figure 4a). The FTIR 
spectrum of the CaF2:Yb,Ho@SiO2 nanofibers reveals a typical 
Si-O-Si asymmetric stretching vibration at 1093 cm-1, Si-O-Si 
symmetric stretching vibration at 808 cm-1, and Si-O-Si bending 
vibration at 464 cm-1, which can be attributed to the SiO2 
matrix. After amino functionalization, a new peak at 1560 cm-1 
appeared, which can be assigned to N-H stretching. The 
functionalization was also verified by studying changes in the 
zeta potential at various stages in the production process. For 
unfunctionalized CaF2:Yb,Ho@SiO2 nanofibers, the zeta 
potential is -13 mV due to the abundance of Si-OH groups on 
 
 
Figure 3 (a) Optical image of CaF2:Yb,Ho@SiO2 nanofiber membrane. (b) SEM (c) TEM images of CaF2:Yb,Ho@SiO2 nanofibers. (d) XRD 
patterns of CaF2:Yb,Ho nanoparticles hydrothermally at 180 °C for 24 h (blue), CaF2:Yb,Ho nanoparticles calcined at 700 °C for 4 h 
(green), CaF2:Yb,Ho@SiO2 nanofibers (purple) and the standard profiles of CaF2 (JCPDS 35-0816) (black). (e) Upconversion 
photoluminescence spectra of CaF2:Yb,Ho nanoparticles calcined at 700 °C for 4 h and CaF2:Yb,Ho@SiO2 nanofibers. 
 
Figure 4 (a) FTIR spectra CaF2:Yb,Ho@SiO2 nanofibers before 
and after amino modification. (b) Zeta potentials of 
CaF2:Yb,Ho@SiO2 nanofibers, CaF2:Yb,Ho@SiO2 -NH2 
nanofibers, CaF2:Yb,Ho@SiO2-Probe 1, AuNPs, and Probe 2- 
conjugated AuNPs. 
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the surface (Figure 4b). After amino functionalization, the 
surface charge was reversed to + 38.2 mV. These data indicate 
the successful amino modification of the CaF2:Yb,Ho@SiO2 
nanofibers to form CaF2:Yb,Ho@SiO2-NH2.  
Subsequently, a carboxyl group-modified probe (Probe 1) 
was covalently grafted onto the CaF2:Yb,Ho@SiO2-NH2 
nanofibers via an amide reaction. The UV-vis spectrum of 
Probe 1 shows a typical absorption peak around 260 nm 
(Figure S4). CaF2:Yb,Ho@SiO2-NH2 nanofibers exhibited a 
‘plain’ absorption spectrum, implying that the nanofibers 
unconjugated with Probe 1 merely absorb light from λ= 230 to 
300 nm. However, in the case of the Probe 1-conjugated 
CaF2:Yb,Ho@SiO2-NH2 nanofibers (CaF2:Yb,Ho@SiO2-Probe 1), 
successful conjugation was confirmed by a new broad peak in 
the UV-vis absorption spectrum at λ=265 nm, and this was 
further supported by the negative zeta potential of 
CaF2:Yb,Ho@SiO2-Probe 1 (– 8.6 mV) resulting from presence 
of the negatively charged oligonucleotide strand. 
2.4 Conjugation of Probe 2 with AuNPs  
The AuNPs were synthesized by a seed-mediated method.45 As 
shown in Figure 5a, the synthesized AuNPs had an average 
diameter of 16.3±2.1 nm. The lattice d-spacing calculated 
from the HRTEM image is 0.235 nm, corresponding to the 
(111) crystal plane of gold (JCPDS No. 04-0784).  
In our design, a thiol group-modified probe (Probe 2) was 
immobilized on the surface of the AuNPs via an Au-S bond. The 
zeta potential of the pure AuNPs was +20.8 mV due to the 
CTAB layer, but this reversed to -9.4 mV after the formation of 
the AuNP-Probe 2 conjugation (Figure 4b). This surface charge 
reversal appeared to confirm that functionalization achieved 
as intended. This result is further supported by UV-vis 
absorption measurements (Figure 5b). The absorption peak for 
the AuNPs was found to be located at ~535 nm and the small 
absorption peak at around 300 nm was due to the CTAB 
coating. After oligonucleotide conjugation, AuNP-Probe 2 
spectrum showed clear evidence of absorbance at 260 nm, 
confirming the successful immobilization of Probe 2 on the 
AuNPs. 
A key result is that the UV-vis absorption spectrum of AuNPs-
Probe 2 overlaps exactly with the strong green emission of the 
CaF2:Yb,Ho@SiO2 nanofibers. This is essential for the FRET 
effect to occur.  
2.5 Detection of miRNA 
The conjugation results presented above, show that it is 
possible to achieve a FRET effect between the 
CaF2:Yb,Ho@SiO2 – Probe 1 (energy donor) and AuNP- Probe 2 
(energy acceptor). In addition, the green emission is much 
stronger as compared with the red emission, which is ideal for 
application as an energy donor in FRET-based analysis. A 
membrane made of Probe 1-containing CaF2:Yb,Ho@SiO2 
nanofibers and Probe 2-conjugated AuNPs was placed in a 20 
mL glass bottle containing 2 mL de-ionised water. The target 
miRNA was then added and co-hybridization occurred between the 
target miRNA and the oligonucleotides. The nanofibers and AuNPs 
were consequently brought into close proximity, triggering the FRET 
effect. As shown in Figure 6a, the intensity of green emission at 541 
nm was quenched significantly, whereas the red emission at 650 
nm remained unchanged, indicating energy transfer from the green 
emission of photoluminescent nanofibers to AuNPs. The green 
emission intensity decreased by about 60 % when the 
concentration of target miRNA was 500 nM. This was due to strong 
absorption by the AuNP-Probe 2 combination at 541 nm and very 
low absorption at 650 nm. As the concentration of target miRNA 
was increased, the intensity of green emission decreased. 
Generally, FRET will occur when the distance between donors and 
acceptors is below 10 nm.46-48 In this work, it is proposed that, with 
increasing miRNA concentration, increasing numbers of AuNPs 
were brought into close proximity and conjugated with the 
nanofibers to provide a suitable acceptor-to-donor distance for 
FRET to occur and this was characterized by quenching of the green 
emission (Figure 7).  
To explore the quenching efficiency of the FRET system, different 
miRNA concentrations, ranging from 2 nM – 500 nM, were tested. 
Figure 6b shows the relationship between the quenching of 
 
Figure 6 (a) UCPL spectra of nanofibers at different 
concentrations of target miRNA. (b) Linear relationship 
between the intensity ratio I541/I650 and the concentration of 
target miRNA (purple); Exponential relationship between the 
quenching UCPL intensity at 541 nm and the concentration of 
target miRNA (blue). 
 
 
Figure 5 (a) SEM and (inset) TEM images of AuNPs; (b) UV-vis 
absorption of AuNPs and AuNP- Probe 2, and UCPL spectra of 
CaF2:Yb,Ho@SiO2 nanofibers.  
 
 
Figure 7 TEM images of AuNPs- Probe 2 conjugated with 
CaF2:Yb,Ho@SiO2upon different concentrations of target 
miRNA: (a) 0, (b) 50 nM, (c) 500 nM. 
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emission intensity ∆I (∆I=(I0-I)/I0) and the concentration of target 
miRNA (where I0 and I represent the green emission intensity of 
CaF2:Yb,Ho@SiO2 nanofibers in the absence and presence of 
different concentrations of target miRNA, respectively). The 
quenching efficiency increased with increasing target miRNA 
concentration and the intensity ratio (I541/I650) was found to vary 
linearly with the concentration of target miRNA. At a miRNA 
concentration of 500 nM, the quenching efficiency reached a value 
of 67 %. 
3 Conclusions 
In summary, a novel UCPL-based FRET biosensor utilizing 
amino-modified CaF2:Yb,Ho@SiO2 nanofibers and AuNPs was 
developed for miRNA-195 detection. The sandwich structure 
formed as a result of co-hybridization of target miRNA via the 
action of oligonucleotides allowed the nanofibers and AuNPs 
to be brought into sufficiently close proximity to trigger a FRET 
effect. The intensity ratio of green to red emission, I541/I650, 
varied linearly with miRNA concentration, allowing the result 
to be utilized as a standard curve for quantitative 
determination target miRNA. This work demonstrates the 
feasibility of using co-conjugated probes, AuNPs and 
nanofibers that can be processed to form a membrane. 
Further work will investigate the use of multiple combinations 
of upconversion photoluminescent particle-impregnated 
nanofibers for the simultaneous detection of several 
biomarkers, relevant to early stage cancer diagnosis.  
4 Materials and Methods 
4.1 Synthesis of CaF2:Yb,Ho Nanoparticles 
CaF2:Yb,Ho nanoparticles were prepared using a hydrothermal 
process based on a method reported by Deng et al. (2015).49 
Calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, 1mmol, A.R., 
Sinopharm Chemical, China), ytterbium nitrate pentahydrate 
(Yb(NO3)3·5H2O, 0.2125 mmol, 99.9 %, Sigma-Aldrich), holmium 
nitrate pentahydrate (Ho(NO3)3·5H2O, 0.0375 mmol, 99.9 %, Sigma-
Aldrich), trisodium citrate (Cit3-, 2 mmol, 99.0 %, Aladdin) and 
sodium fluoroborate (NaBF4, 2 mmol, 99.99 %, Aladdin) were 
dissolved in 40 mL of deionized water and ammonia solution was 
added to maintain the pH at 7.0. The solution was transferred into a 
50 ml stainless-steel Teflon autoclave and maintained at 180 °C for 
24 h. The precipitate obtained was collected by centrifugation, 
washed and dried at 80 °C for 24 h to obtain CaF2:Yb,Ho 
nanoparticles. The CaF2:Yb,Ho nanoparticles obtained were then 
calcined at 700 °C for 4 h. 
4.2 Fabrication of CaF2:Yb,Ho@SiO2 Nanofibers 
1.67 g of tetraethyl orthosilicate (TEOS, A.R., Sinopharm Chemical, 
China), 200 µL of acetic acid (A.R., Sinopharm Chemical, China), 600 
µL of deionized water and 10 mL of ethanol (99.9 vol %, Sinopharm 
Chemical, China) were mixed by stirring for 1.5 h. Then 1.5 mL of 
N,N-dimethylformamide (DMF, A.R., Sinopharm Chemical, China), 
1.2 g of polyvinylpyrrolidone (PVP, Mw =1 300 000, Aladdin), and 50 
mg of the calcined CaF2:Yb,Ho nanoparticles were added and stirred 
for 2 h to obtain the electrospinning precursor. 
For the electrospinning process, the precursor solution was 
transferred into a single nozzle electrospinning setup. The flow rate 
was set at 1.5 mL/h. The distance and the high voltage between the 
needle tip and the collector were set at 15 cm and 8-11 kV, 
respectively. The as-spun composite nanofibers were dried at 80 °C 
overnight and calcined at 600 °C for 4 h. 
4.3 Functionalization of CaF2:Yb,Ho@SiO2 Nanofibers with Amino 
Groups  
100 mg of CaF2:Yb,Ho@SiO2 nanofibers and 0.8 mL of 3-
aminopropyl-triethoxysilane (APTES, 99 %, Macklin) were dispersed 
in 40 mL of DMF and stirred at 80 °C for 24 h. Then the nanofibers 
were centrifuged and washed three times with DMF to obtain 
amino modified CaF2:Yb,Ho@SiO2 nanofibers (CaF2:Yb,Ho@SiO2-
NH2). 
4.4 Conjugation of Probe 1 with CaF2:Yb,Ho@SiO2 Nanofibers 
In order to covalently conjugate Probe 1 to CaF2:Yb,Ho@SiO2-NH2 
nanofibers, carboxyl group-modified miRNA-capturing 
oligonucleotide 1 (Probe 1, 5’-COOH AAAAAGCCAATATTTC-3’, 25 
µL, 100 µM, Sangon Biotechnology Co., Ltd. Shanghai, China), N-
hydroxy-succinimide (NHS, 200 µL, 2 mg/mL, 97.0～102.0 %, 
Sinopharm Chemical, China) and 1-ethyl-3-(3-dimethylaminopropy) 
carbodiimide (EDC, 400 µL, 2 mg/mL, 98.0 %, Aladdin) were 
incubated in 2.5 mL of ultrapure water at 37 °C for 1 h. Then, 5 mg 
of CaF2:Yb,Ho@SiO2-NH2 nanofibers were added into the solution 
and reacted at 37 °C for 24 h. The conjugates formed were 
centrifuged with water three times and then redispersed in 800 µL 
of water. 
4.5 Synthesis of Gold Nanoparticles  
4.5.1 Seed Solution 
The gold nanoparticles (AuNPs) were fabricated according to a 
modified version of the well-established seed-mediated growth 
method.45 Briefly, CTAB aqueous solution (5 mL, 0.2 M, A.R., 
Sinopharm Chemical, China) was mixed with HAuCl4 (5 mL, 0.5 mM, 
A.R. Sinopharm Chemical, China) and ice-cold NaBH4 (0.6 mL, 0.01 
M, 96 %, Sinopharm Chemical, China) under vigorous stirring for 2 
min. Then the brownish-yellow seed solution was aged at room 
temperature for 3 h before use.  
4.5.2 Growth Solution 
The growth solution was made from solutions of CTAB (0.2 M, 6 
mL), HAuCl4 (0.5 mM, 6 mL), and ascorbic acid (0.1 M, 4.5 mL, 99.7 
%, Sinopharm Chemical, China). The gold seed solution (0.3 mL) was 
then injected into the growth solution and the mixture was stirred 
for 1 h and left undisturbed overnight. The AuNPs obtained were 
centrifuged to remove excess CTAB and ascorbic acid, re-suspended 
and concentrated 50-fold in 0.005 M CTAB solution for the 
following experiments. 
4.6 Synthesis of AuNP-Probe 2 Conjugation 
The modification of AuNPs was conducted following a modified 
version of protocols reported previously by Yi et al., Xu et al., Liu et 
al. and Zhang et al. 50-53  A volume of 60 µL, 100 mM thiol-modified 
miRNA-capturing oligonucleotide 2 (Probe 2, 5’ 
TGTGCTGCTAAAAAA SH-3’, Sangon Biotechnology Co., Ltd. 
Shanghai, China) was pipetted into a micro centrifuge tube. Then 1 
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µL of 10 mM fresh Tris-(2-carboxyethyl) phosphine hydrochloride 
(TCEP, ≥ 98 %, Sigma-Aldrich.) was added to the tube to activate the 
thiol-modified Probe 2. The sample was incubated at room 
temperature for 1 h, before 300 µL of the prepared AuNP solution 
into the tube. The mixture was then allowed to react at 25 °C for at 
least 16 h in the dark with gentle shaking. After incubation, the 
conjugate was collected after three consecutive purification cycles 
comprising centrifugation for 10 min at 6000 rpm and redispersed 
in 0.005 M CTAB buffer. The conjugate was stored at 4 °C. 
4.7 Detection of Target MiRNA Based on the FRET System 
800 µl of CaF2:Yb,Ho@SiO2-NH2 –Probe 1 solution, 800 µl of AuNP-
Probe 2, and 400 µL of target miRNA (miRNA 195, 
UAGCAGCACAGAAAUAUUGGC, Sangon Biotechnology Co., Ltd. 
Shanghai, China), with concentrations ranging from 2 nM to 500 
nM, were mixed and incubated at 25 °C for 1 h. The mixture was 
centrifuged, washed twice with water and re-suspended in 2 mL of 
water. 
4.8 Characterization 
The morphologies and microstructures of the CaF2:Yb,Ho 
nanoparticles, CaF2:Yb,Ho@SiO2 nanofibers, AuNPs, and AuNPs 
conjugated CaF2:Yb,Ho@SiO2 nanofibers were characterized using 
field emission scanning electron microscopy (FESEM, SU-70, Hitachi) 
and high-resolution transmission electron microscopy (HRTEM, 
Tecnai F20, FEI). The XRD patterns were recorded using a RIGAKU 
D/MAX 2550/PC multi crystal diffractometer. FTIR spectra were 
measured on a Perkin-Elmer 580B (Tensor 27, Bruker) infrared 
spectrophotometer using the KBr pellet technique. UV-vis 
spectroscopy measurements were performed on TU-1810 UV-vis 
spectrophotometer. Measurements of zeta potential were collected 
on a zetasizer (Zetasizer 3000 HSA, Malvern). Diluted aqueous 
solution of samples were performed in quintuplicates. The UCPL 
spectra were obtained under the excitation of a continuous laser 
with a wavelength of 980 nm from a fluorescence 
spectrophotometer (PL, FLSP920, Edinburgh). The diameter 
distributions were obtained by stochastically choosing and 
measuring of fifty fibers from SEM images. 
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